I think these ASX blue chips shares are primed for a major rebound in 2026

2025 was not kind to these shares. Here's why things could be better next year.

| More on:
Two men laughing while bouncing on bouncy balls

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL Ltd is well-positioned for a rebound due to its robust presence in global healthcare and ongoing investments, despite recent market anxieties and temporary operational challenges.
  • WiseTech Global's CargoWise platform retains strong growth potential amid recent setbacks; with a recovery in sentiment and successful business adjustments, it could experience a significant upswing.
  • The article highlights opportunities arising from market impatience, encouraging a long-term perspective to capitalise on undervalued high-quality stocks.

Every market cycle produces its winners and losers. And sometimes, the losers aren't poor-quality companies at all, they are simply dealing with temporary headwinds.

That's what makes times like these so interesting. Several high-quality ASX blue chips have been marked down over the past year, not because their businesses are broken, but because the market has lost patience.

For investors who are willing to look beyond the next quarter, that disconnect can create attractive entry points.

Here are two ASX blue chip shares I believe are primed for a major rebound in 2026.

CSL Ltd (ASX: CSL)

CSL has spent decades earning its reputation as one of the highest-quality companies on the ASX. Its plasma therapies, vaccines, and specialty medicines give it a deeply entrenched position in global healthcare, which is a sector where scale, expertise, and regulatory trust matter enormously.

Yet despite this, CSL shares have been hit hard in 2025. Concerns over a margin recovery at CSL Behring, uncertainty surrounding the Seqirus demerger, weak influenza vaccine rates in the United States, and noise around US tariff policy have clouded what remains a fundamentally strong long-term outlook.

Strip out the market anxiety, and the underlying story hasn't changed for this biotech. Plasma collections continue to rise, new therapies are advancing through its R&D pipeline, and CSL is investing heavily in North American manufacturing to support future growth. The company's earnings power and competitive moat remain intact.

It is rare to see CSL trading at such a meaningful discount to its long-term averages. If sentiment improves in 2026, this blue chip ASX share could be one of the ASX's rebound stories.

Wisetech Global Ltd (ASX: WTC)

WiseTech has transformed global logistics software with its flagship CargoWise platform, which is now used by some of the biggest freight forwarders and supply-chain operators on the planet. Its model is sticky, scalable, and increasingly global, which is the kind of combination tech investors dream about.

However, the past year brought a rare step backwards in market sentiment. Founder controversies, delays to product launches, and a shift to its business model have led to a significant share price pullback. But none of these issues reflect a deterioration in the long-term fundamentals.

CargoWise continues to expand its reach through acquisitions, large enterprise customers are deepening their usage, and WiseTech is still growing at a strong rate.

If its performance improves, it stays clear of further controversies, and transitions successfully to its new business model in 2026, I think the rebound could be sharp for this blue chip ASX share.

Motley Fool contributor James Mickleboro has positions in CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A group of businesspeople clapping.
Blue Chip Shares

3 ASX 200 shares for smart investors to buy and hold

Not sure where to invest? Here are three smart picks for January.

Read more »

A woman looks at a tablet device while in the aisles of a hardware style store amid stacked boxes on shelves representing Bunnings and the Wesfarmers share price
Blue Chip Shares

Wesfarmers vs Coles: Which ASX share is the best buy?

Coles offers simplicity. Wesfarmers offers diversification, capital discipline, and long-term optionality.

Read more »

Three rock climbers hang precariously off a steep cliff face, each connected to the other with the higher person holding on and the two below them connected by their arms and rope but not making contact with the cliff face.
Blue Chip Shares

3 reasons some brokers think it's time to sell CBA shares

Brokers see more losses ahead for the banking giant.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Blue Chip Shares

A once-in-a-decade opportunity to buy CSL shares?

This biotech giant could have major upside potential in 2026.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Blue Chip Shares

Top Australian stocks to buy with $2,000 right now

Let's see why these top stocks could be great destinations for your hard-earned money.

Read more »

a woman sits in comtemplation with superimposed images of piles of gold coins, graphs and star-like lights above her head as though she is thinking about investment options.
Blue Chip Shares

If I invest $15,000 in Macquarie shares, how much passive income will I receive in 2026?

Is Macquarie a great option for dividend income?

Read more »

The word growth with bles arrows shooting up above it, indicating a share price movement for ASX growth stocks
Blue Chip Shares

2 great ASX 200 blue-chip shares I'd buy right now!

These industry-leading businesses look much better value today.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Blue Chip Shares

The outstanding Australian shares I'd be happy owning forever

Let's see why these shares could be worthy of a spot in your investment portfolio.

Read more »